The NIBIT - Italian network for cancer biotherapy and immunotherapy - was established in 2004, to respond to the need to create a cooperative network that would collect and coordinate the activities of several Italian groups involved in biotherapy and immunotherapy of cancer.

Numerous groups, over the years, have joined the NIBIT with a consequent progressive growth of the network and a greater activity in terms of projects, initiatives and collaborations.
In consideration of this development, the NIBIT was established in 2006 as a non-profit association.

The objectives of the NIBIT are:
a) to promote and develop scientific, professional and operational interaction between professionals (academy, industry, regulatory agencies) involved in cancer biotherapy;
b) to develop and conduct clinical biotherapy studies on tumors;
c) to develop initiatives aimed at directing and informing cancer patients about clinical trials in the network.

Attualmente il NIBIT si compone di un Consiglio Direttivo con un Presidente, un Segretario/Tesoriere e sette Consiglieri. L’Assemblea dei Soci è costituita da membri che rappresentano i principali gruppi italiani di ricerca clinica e pre-clinica in ambito oncologico.

Ad oggi fanno parte del NIBIT numerosi gruppi di lavoro in rappresentanza di diverse istituzioni sanitarie, universitarie ed agenzie regolatorie nazionali.